Yüklüyor......

Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus

The humanized anti-CD22 antibody, epratuzumab, has demonstrated therapeutic activity in clinical trials of lymphoma, leukemia and autoimmune diseases, treating currently over 1500 cases of non-Hodgkin lymphoma, acute lymphoblastic leukemias, Waldenström’s macroglobulinemia, Sjögren’s syndrome, and s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Rossi, Edmund A., Chang, Chien-Hsing, Goldenberg, David M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2014
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4026529/
https://ncbi.nlm.nih.gov/pubmed/24841238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0098315
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!